Status:
UNKNOWN
Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects
Lead Sponsor:
University Hospital, Akershus
Conditions:
Defect of Articular Cartilage
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to: * Compare the treatment efficacy of autologous mesenchymal stem cells (Mesenchymal Stem Cells) versus chondrocytes implanted in a commercial available scaffold in a h...
Detailed Description
Musculoskeletal diseases are growing in the Norwegian population and are currently the largest group of the chronic diseases (31%). Musculoskeletal diseases are the largest cause of disability on the ...
Eligibility Criteria
Inclusion
- Norwegian citizens
- A full-thickness cartilage lesion (diameter \> 15 mm, but less than 6 cm2 and Lysholm score \< 75 points) located on the femoral condyle
Exclusion
- Patients with malignment of the knee
- Other knee pathology such as ACL injury or a nontreated meniscus injury will not be included in the study to avoid the impact of these knee pathologies on the final results
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00885729
Start Date
April 1 2009
End Date
July 1 2018
Last Update
October 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo UniversityHospital-Ullevaal
Oslo, Oslo County, Norway, 0481